Differentiation and functional regulation of human fetal NK cells

Journal of Clinical Investigation

Volumn 123, Issue 9, 2013, Pages 3889-3901

  Ivarsson, Martin A ^a   Loh, Liyen ^b,c   Marquardt, Nicole ^a   Kekäläinen, Eliisa ^a   Berglin, Lena ^a   Björkström, Niklas K ^a   Westgren, Magnus ^a   Nixon, Douglas F ^b   Michaëlsson, Jakob ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; CD57 ANTIGEN; CYTOKINE; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C;

CELL DIFFERENTIATION; CELL FUNCTION; CONFERENCE PAPER; FETUS; HLA SYSTEM; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TARGET CELL; ANTIBODY SPECIFICITY; CYTOLOGY; DEGRANULATION; FEMALE; FETOMATERNAL TRANSFUSION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; K562 CELL LINE; LUNG; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANTIGENS, CD57; CELL DEGRANULATION; CELL DIFFERENTIATION; CYTOKINES; FEMALE; FETUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; K562 CELLS; KILLER CELLS, NATURAL; LUNG; MATERNAL-FETAL EXCHANGE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; ORGAN SPECIFICITY; PREGNANCY; RECEPTORS, KIR; TRANSFORMING GROWTH FACTOR BETA;

EID: 84883520113     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI68989     Document Type: Conference Paper

References (53)

1. Caligiuri MA. Human natural killer cells. Blood . 2008;112(3):461-469.
2. Trowsdale J, Moffett A. NK receptor interactions with MHC class I molecules in pregnancy. Semin Immunol. 2008;20(6):317-320.
3. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274. (Pubitemid 40563170)
4. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22(11):633-640. (Pubitemid 33043908)
5. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood. 2010;115(11):2167-2176.
6. Martin-Fontecha A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol. 2004;5(12):1260-1265. (Pubitemid 41057741)
7. Narni-Mancinelli E, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science. 2012;335(6066):344-348.
8. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature. 2012;481(7381):394-398.
9. Marchant A, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest. 2003;111(11):1747-1755. (Pubitemid 38057755)
10. Mold JE, McCune JM. Immunological tolerance during fetal development: from mouse to man. Adv Immunol. 2012;115:73-111.
11. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol. 2006;121(3):251-259. (Pubitemid 44768008)
12. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007;7(5):379-390. (Pubitemid 46674489)
13. Garcia AM, Fadel SA, Cao S, Sarzotti M. T cell immunity in neonates. Immunol Res. 2000;22(2-3):177-190. (Pubitemid 32382232)
14. Tang Y, et al. Emergence of NK-cell progenitors and functionally competent NK-cell lineage subsets in the early mouse embryo. Blood. 2012;120(1):63-75.
15. Marcoe JP, et al. TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy. Nat Immunol. 2012;13(9):843-850.
16. Michaelsson J, Mold JE, McCune JM, Nixon DF. Regulation of T cell responses in the developing human fetus. J Immunol. 2006;176(10):5741-5748.
17. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med. 1992;175(4):1055- 1066.
18. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA. 2004;291(9):1127-1131. (Pubitemid 38541691)
19. Mold JE, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science. 2008;322(5907):1562- 1565.
20. Robbins JR, Bakardjiev AI. Pathogens and the placental fortress. Curr Opin Microbiol. 2012;15(1):36-43.
21. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity . 2006;25(2):331-342. (Pubitemid 44224147)
22. Schonberg K, Fischer JC, Kogler G, Uhrberg M. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood. 2011;117(19):5152-5156.
23. Yawata M, Yawata N, Draghi M, Partheniou F, Little AM, Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood. 2008;112(6):2369-2380.
24. Hoglund P, Brodin P. Current perspectives of natural killer cell education by MHC class I molecules. Nat Rev Immunol. 2010;10(10):724-734.
25. Bjorkstrom NK, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood. 2010;116(19):3853-3864.
26. Meadows SK, Eriksson M, Barber A, Sentman CL. Human NK cell IFN-gamma production is regulated by endogenous TGF-β. Int Immunopharmacol. 2006;6(6):1020-1028. (Pubitemid 44389418)
27. Trotta R, et al. TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and anti-body-dependent cellular cytotoxicity in human NK cells. J Immunol. 2008;181(6):3784-3792.
28. Milush JM, et al. Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4. Blood. 2009;114(23):4823-4831.
29. Freud AG, et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med . 2006;203(4):1033-1043.
30. Deutch G, Pinar H. Prenatal lung development. In: Voelkel NF, MacNee W, eds. Chronic Obstructive Lung Diseases. Hamilton, Ontario, Canada: BC Decker; 2002:7-20.
31. Yu J, et al. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood . 2010;115(2):274-281.
32. Alhajjat AM, Durkin ET, Shaaban AF. Regulation of the earliest immune response to in utero hematopoietic cellular transplantation. Chimerism. 2010;1(2):61-63.
33. Lopez-Verges S, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood . 2010;116(19):3865-3874.
34. Andersson S, Fauriat C, Malmberg JA, Ljunggren HG, Malmberg KJ. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood. 2009;114(1):95-104.
35. Bjorklund AT, et al. NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLAmatched sibling stem cell transplantation. Blood. 2010;115(13):2686-2694.
36. Fauriat C, et al. Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J Immunol. 2008;181(9):6010-6019.
37. Burt BM, et al. The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors. J Immunol. 2009;183(3):1789-1796.
38. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.
39. Al-Buhtori M, Moore L, Benbow EW, Cooper RJ. Viral detection in hydrops fetalis, spontaneous abortion, and unexplained fetal death in utero. J Med Virol. 2011;83(4):679-684.
40. Iwasenko JM, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis. 2011;203(11):1526-1533.
41. de Vries JI, Visser GH, Prechtl HF. The emergence of fetal behaviour. II. Quantitative aspects. Early Hum Dev. 1985;12(2):99-120. (Pubitemid 16222676)
42. .Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425-433.
43. Bry K, Lappalainen U, Hallman M. Cytokines and production of surfactant components. Semin Perinatol. 1996;20(3):194-205. (Pubitemid 26282565)
44. Nelson JL. The otherness of self: microchimerism in health and disease. Trends Immunol . 2012;33(8):421-427.
45. .Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature. 2012;490(7418):102-106.
46. .Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol . 2006;7(3):241-246.
47. .Gordon SM, et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36(1):55-67.
48. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436(7051):709-713. (Pubitemid 41117274)
49. Guia S, et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal. 2011;4(167):ra21.
50. Bjorkstrom NK, et al. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood. 2012;120(17):3455-3465.
51. Mold JE, et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science. 2010;330(6011):1695-1699.
52. Herzenberg LA. Toward a layered immune system. Cell. 1989;59(6):953-954. (Pubitemid 20024606)
53. Yuan J, Nguyen CK, Liu X, Kanellopoulou C, Muljo SA. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science. 2012;335(6073):1195-1200.